EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)
Therapeutic Advances in Childhood Leukemia Consortium
Therapeutic Advances in Childhood Leukemia Consortium
South Plains Oncology Consortium
Therapeutic Advances in Childhood Leukemia Consortium
Children's Mercy Hospital Kansas City
Gilead Sciences
Therapeutic Advances in Childhood Leukemia Consortium
National Cancer Institute (NCI)